Rank | Gene Set | Z-score |
---|---|---|
1 | phototransduction (GO:0007602) | 8.53831863 |
2 | detection of light stimulus (GO:0009583) | 8.51023943 |
3 | positive regulation of guanylate cyclase activity (GO:0031284) | 8.43793928 |
4 | detection of visible light (GO:0009584) | 8.25419212 |
5 | GMP metabolic process (GO:0046037) | 8.18888370 |
6 | phototransduction, visible light (GO:0007603) | 8.16421328 |
7 | regulation of guanylate cyclase activity (GO:0031282) | 7.81157620 |
8 | visual perception (GO:0007601) | 7.64208894 |
9 | sensory perception of light stimulus (GO:0050953) | 7.60623341 |
10 | protein-chromophore linkage (GO:0018298) | 6.90964140 |
11 | cellular response to light stimulus (GO:0071482) | 6.67021587 |
12 | retina development in camera-type eye (GO:0060041) | 6.05237039 |
13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.89042437 |
14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.89042437 |
15 | modulation by symbiont of host immune response (GO:0052553) | 5.89042437 |
16 | positive regulation by symbiont of host defense response (GO:0052509) | 5.89042437 |
17 | modulation by symbiont of host defense response (GO:0052031) | 5.89042437 |
18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.89042437 |
19 | detection of external stimulus (GO:0009581) | 5.88545845 |
20 | detection of abiotic stimulus (GO:0009582) | 5.79172886 |
21 | neutrophil activation involved in immune response (GO:0002283) | 5.68848174 |
22 | eye photoreceptor cell differentiation (GO:0001754) | 5.65612328 |
23 | photoreceptor cell differentiation (GO:0046530) | 5.65612328 |
24 | regulation of cGMP metabolic process (GO:0030823) | 5.59019463 |
25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.58410887 |
26 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.32899848 |
27 | response to peptidoglycan (GO:0032494) | 5.13667745 |
28 | positive regulation of cGMP biosynthetic process (GO:0030828) | 5.11806575 |
29 | negative regulation of cell killing (GO:0031342) | 5.04666912 |
30 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.04666912 |
31 | detection of molecule of bacterial origin (GO:0032490) | 5.03573381 |
32 | macrophage activation involved in immune response (GO:0002281) | 4.96599298 |
33 | regulation of cGMP biosynthetic process (GO:0030826) | 4.91972573 |
34 | cellular potassium ion homeostasis (GO:0030007) | 4.89738369 |
35 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.81817430 |
36 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.68708135 |
37 | detection of other organism (GO:0098543) | 4.66567097 |
38 | neutrophil activation (GO:0042119) | 4.52564837 |
39 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.52376569 |
40 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.48379849 |
41 | nonmotile primary cilium assembly (GO:0035058) | 4.44289932 |
42 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.42553874 |
43 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.41646543 |
44 | positive regulation of cGMP metabolic process (GO:0030825) | 4.40758815 |
45 | detection of external biotic stimulus (GO:0098581) | 4.37948506 |
46 | cellular response to radiation (GO:0071478) | 4.36797379 |
47 | response to pheromone (GO:0019236) | 4.34687266 |
48 | regulation of voltage-gated calcium channel activity (GO:1901385) | 4.31159143 |
49 | negative regulation of interleukin-12 production (GO:0032695) | 4.30913895 |
50 | respiratory burst (GO:0045730) | 4.28339196 |
51 | granulocyte activation (GO:0036230) | 4.24045360 |
52 | cellular extravasation (GO:0045123) | 4.17958134 |
53 | detection of bacterium (GO:0016045) | 4.17309120 |
54 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.13531164 |
55 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 4.12500638 |
56 | regulation of clathrin-mediated endocytosis (GO:2000369) | 4.08566102 |
57 | response to host immune response (GO:0052572) | 4.06926078 |
58 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.06926078 |
59 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.03215390 |
60 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.02938384 |
61 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.99352134 |
62 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.99352134 |
63 | response to histamine (GO:0034776) | 3.97573516 |
64 | macrophage activation (GO:0042116) | 3.95172959 |
65 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.94503661 |
66 | behavioral response to ethanol (GO:0048149) | 3.93994969 |
67 | potassium ion homeostasis (GO:0055075) | 3.88665996 |
68 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.87944853 |
69 | detection of biotic stimulus (GO:0009595) | 3.80023572 |
70 | myeloid cell activation involved in immune response (GO:0002275) | 3.68171757 |
71 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.67543500 |
72 | response to host (GO:0075136) | 3.67543500 |
73 | response to host defenses (GO:0052200) | 3.67543500 |
74 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.67038378 |
75 | sensory perception (GO:0007600) | 3.66850682 |
76 | microglial cell activation (GO:0001774) | 3.65328707 |
77 | neutrophil mediated immunity (GO:0002446) | 3.64012908 |
78 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.61546390 |
79 | regulation of mast cell degranulation (GO:0043304) | 3.61486748 |
80 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.58093997 |
81 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.52791201 |
82 | retina homeostasis (GO:0001895) | 3.52622712 |
83 | regulation of leukocyte degranulation (GO:0043300) | 3.49628003 |
84 | response to light stimulus (GO:0009416) | 3.48180383 |
85 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.44175642 |
86 | immunoglobulin mediated immune response (GO:0016064) | 3.43321366 |
87 | regulation of gamma-delta T cell activation (GO:0046643) | 3.41529417 |
88 | regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 3.40547876 |
89 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.40006412 |
90 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.39255254 |
91 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.38396959 |
92 | sodium ion export (GO:0071436) | 3.38354141 |
93 | leukocyte aggregation (GO:0070486) | 3.37168453 |
94 | positive regulation of synapse maturation (GO:0090129) | 3.36675868 |
95 | response to interleukin-15 (GO:0070672) | 3.30759723 |
96 | membrane hyperpolarization (GO:0060081) | 3.30622731 |
97 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.28664110 |
98 | neuron development (GO:0048666) | 3.28371480 |
99 | leukocyte degranulation (GO:0043299) | 3.26672242 |
100 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.24542648 |
101 | regulation of penile erection (GO:0060405) | 3.23514574 |
102 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.23056922 |
103 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.22663729 |
104 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.22399087 |
105 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.20957770 |
106 | prenylation (GO:0097354) | 3.20466393 |
107 | protein prenylation (GO:0018342) | 3.20466393 |
108 | protein localization to synapse (GO:0035418) | 3.20037249 |
109 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.18781244 |
110 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.18761206 |
111 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.18270288 |
112 | positive regulation of interferon-alpha production (GO:0032727) | 3.18211969 |
113 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.13202612 |
114 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.12904384 |
115 | interferon-gamma secretion (GO:0072643) | 3.11576333 |
116 | regulation of regulated secretory pathway (GO:1903305) | 3.10756196 |
117 | positive regulation of regulated secretory pathway (GO:1903307) | 3.10320884 |
118 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.09404542 |
119 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.08659690 |
120 | dendritic cell migration (GO:0036336) | 3.04762246 |
121 | positive regulation of leukocyte degranulation (GO:0043302) | 3.01472250 |
122 | adaptation of signaling pathway (GO:0023058) | 3.01128983 |
123 | protein heterotetramerization (GO:0051290) | 3.00918649 |
124 | regulation of interferon-alpha production (GO:0032647) | 3.00346777 |
125 | positive regulation of neurotransmitter transport (GO:0051590) | 2.99905212 |
126 | striatum development (GO:0021756) | 2.96136444 |
127 | positive regulation of mast cell activation (GO:0033005) | 2.96134118 |
128 | dendritic cell chemotaxis (GO:0002407) | 2.95430462 |
129 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.94388311 |
130 | myeloid leukocyte mediated immunity (GO:0002444) | 2.93613552 |
131 | type I interferon signaling pathway (GO:0060337) | 2.92701876 |
132 | cellular response to type I interferon (GO:0071357) | 2.92701876 |
133 | regulation of mast cell activation (GO:0033003) | 2.92358963 |
134 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.92171564 |
135 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.91776946 |
136 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.90882098 |
137 | response to type I interferon (GO:0034340) | 2.90306501 |
138 | lipoprotein transport (GO:0042953) | 2.90014196 |
139 | cellular response to interleukin-15 (GO:0071350) | 2.88451494 |
140 | arachidonic acid secretion (GO:0050482) | 2.88216908 |
141 | icosanoid secretion (GO:0032309) | 2.88216908 |
142 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.88168104 |
143 | sensory perception of smell (GO:0007608) | 2.85046242 |
144 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.84351390 |
145 | neutrophil chemotaxis (GO:0030593) | 2.82323358 |
146 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.82281277 |
147 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.82281277 |
148 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.81427269 |
149 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.80490592 |
150 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 2.78345580 |
151 | myeloid leukocyte activation (GO:0002274) | 2.77642882 |
152 | B cell mediated immunity (GO:0019724) | 2.77449139 |
153 | neutrophil migration (GO:1990266) | 2.75192461 |
154 | germinal center formation (GO:0002467) | 2.74626138 |
155 | positive regulation of interferon-beta production (GO:0032728) | 2.72560300 |
156 | negative regulation of cation channel activity (GO:2001258) | 2.69658312 |
157 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.69591430 |
158 | chemosensory behavior (GO:0007635) | 2.68444505 |
159 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.67567706 |
160 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.67567706 |
161 | positive regulation of mast cell degranulation (GO:0043306) | 2.66825447 |
162 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.66825447 |
163 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.66812169 |
164 | protein localization to endosome (GO:0036010) | 2.66496473 |
165 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.65746416 |
166 | regulation of tolerance induction (GO:0002643) | 2.63221218 |
167 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.62688006 |
168 | I-kappaB phosphorylation (GO:0007252) | 2.62623162 |
169 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.60604922 |
170 | post-embryonic morphogenesis (GO:0009886) | 2.58910041 |
171 | innervation (GO:0060384) | 2.58394992 |
172 | dopamine receptor signaling pathway (GO:0007212) | 2.58111279 |
173 | regulation of neurotransmitter uptake (GO:0051580) | 2.56029515 |
174 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.55120818 |
175 | synaptic vesicle maturation (GO:0016188) | 2.53604690 |
176 | synaptic transmission, dopaminergic (GO:0001963) | 2.52879551 |
177 | retina layer formation (GO:0010842) | 2.52764927 |
178 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.52731399 |
179 | regulation of synapse maturation (GO:0090128) | 2.52658805 |
180 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.50510601 |
181 | short-term memory (GO:0007614) | 2.49174012 |
182 | synaptic vesicle endocytosis (GO:0048488) | 2.48677718 |
183 | behavioral response to cocaine (GO:0048148) | 2.47883577 |
184 | sensory perception of chemical stimulus (GO:0007606) | 2.47633602 |
185 | estrogen biosynthetic process (GO:0006703) | 2.45606159 |
186 | response to radiation (GO:0009314) | 2.44545281 |
187 | synaptic vesicle exocytosis (GO:0016079) | 2.41257252 |
188 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.39916484 |
189 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.38476126 |
190 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.32332967 |
191 | righting reflex (GO:0060013) | 2.31535258 |
192 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 14.5640584 |
193 | rhodopsin mediated signaling pathway (GO:0016056) | 14.3452801 |
194 | retinal cone cell development (GO:0046549) | 13.8235302 |
195 | detection of light stimulus involved in sensory perception (GO:0050962) | 12.1922914 |
196 | detection of light stimulus involved in visual perception (GO:0050908) | 12.1922914 |
197 | photoreceptor cell development (GO:0042461) | 11.0817739 |
198 | retinal rod cell development (GO:0046548) | 10.7772188 |
199 | eye photoreceptor cell development (GO:0042462) | 10.6873349 |
200 | photoreceptor cell maintenance (GO:0045494) | 10.1093095 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 4.56915341 |
2 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 4.29572096 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.25147572 |
4 | VDR_22108803_ChIP-Seq_LS180_Human | 3.93837602 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.80368090 |
6 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 3.28027568 |
7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.24010969 |
8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.13872262 |
9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.11549379 |
10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.09424586 |
11 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 3.04119219 |
12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.97834393 |
13 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.93007970 |
14 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 2.82072085 |
15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.75964590 |
16 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.75288046 |
17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.65573294 |
18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.59502259 |
19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.55361687 |
20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.49133874 |
21 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.45631385 |
22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.44207339 |
23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.40138110 |
24 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.38199141 |
25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.19674163 |
26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.15418480 |
27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.08234028 |
28 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.07876684 |
29 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 2.03116718 |
30 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.99886218 |
31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.94774947 |
32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.92357476 |
33 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.90661525 |
34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.90204102 |
35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.87963027 |
36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.86619616 |
37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.86360859 |
38 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.83042978 |
39 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.81663585 |
40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.80477975 |
41 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.78088640 |
42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77547165 |
43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77393333 |
44 | MYB_26560356_Chip-Seq_TH2_Human | 1.74795674 |
45 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.74026572 |
46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72354904 |
47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.70791543 |
48 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.70621312 |
49 | MAF_26560356_Chip-Seq_TH1_Human | 1.70564500 |
50 | MYB_26560356_Chip-Seq_TH1_Human | 1.66390439 |
51 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.65942824 |
52 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.65470450 |
53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.65220248 |
54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.64622207 |
55 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.64539869 |
56 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.64539869 |
57 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.64539869 |
58 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.60292481 |
59 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.58770208 |
60 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.57744273 |
61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.55870180 |
62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53968690 |
63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.52599230 |
64 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.52248167 |
65 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.51787572 |
66 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.50760756 |
67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.49282324 |
68 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.49171347 |
69 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.46453993 |
70 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.46102805 |
71 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.45894811 |
72 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.43771548 |
73 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.43086245 |
74 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43014678 |
75 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.42485353 |
76 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41956099 |
77 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.40912729 |
78 | UTX_26944678_Chip-Seq_JUKART_Human | 1.40487126 |
79 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.39659607 |
80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.39145937 |
81 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.39114307 |
82 | MYC_22102868_ChIP-Seq_BL_Human | 1.38591275 |
83 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.37722978 |
84 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.37414460 |
85 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.36614663 |
86 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.36266522 |
87 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35799842 |
88 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.35711451 |
89 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.35246407 |
90 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34698838 |
91 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.34291292 |
92 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.32227970 |
93 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31113481 |
94 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.30708101 |
95 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.29651920 |
96 | * KAP1_27257070_Chip-Seq_ESCs_Mouse | 1.29585060 |
97 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29531291 |
98 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29218469 |
99 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28797809 |
100 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28523580 |
101 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.28061257 |
102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.26339812 |
103 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26028560 |
104 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.25674075 |
105 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25581753 |
106 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.24571659 |
107 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.23778392 |
108 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22954533 |
109 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22276134 |
110 | GATA2_19941826_ChIP-Seq_K562_Human | 1.22267244 |
111 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21888303 |
112 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.21427102 |
113 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.20931382 |
114 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.20648126 |
115 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.19220212 |
116 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18778328 |
117 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.18154196 |
118 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17953704 |
119 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17398537 |
120 | AR_19668381_ChIP-Seq_PC3_Human | 1.17344606 |
121 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16398925 |
122 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.16264981 |
123 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.15149091 |
124 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.13922713 |
125 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13789343 |
126 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13699049 |
127 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.13248619 |
128 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.13115905 |
129 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.12857394 |
130 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12523538 |
131 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.12336313 |
132 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.11676383 |
133 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11601993 |
134 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11348334 |
135 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.11101883 |
136 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10780077 |
137 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.10168761 |
138 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10124856 |
139 | MAF_26560356_Chip-Seq_TH2_Human | 1.09897787 |
140 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09152256 |
141 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.08689190 |
142 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08585956 |
143 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.08312541 |
144 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.08305648 |
145 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.07023635 |
146 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.06753256 |
147 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.06736096 |
148 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.06469669 |
149 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06231677 |
150 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.05087539 |
151 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04847034 |
152 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.04720269 |
153 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04515855 |
154 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.03992381 |
155 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02522547 |
156 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02470122 |
157 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01210538 |
158 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01161000 |
159 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00989280 |
160 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.99277759 |
161 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98382888 |
162 | P68_20966046_ChIP-Seq_HELA_Human | 0.97478467 |
163 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.97168532 |
164 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.97168532 |
165 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94659357 |
166 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.94335745 |
167 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.94244660 |
168 | NCOR_22424771_ChIP-Seq_293T_Human | 0.93456231 |
169 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.93209827 |
170 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.91881490 |
171 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.90875436 |
172 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.87966433 |
173 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.87670824 |
174 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.86772290 |
175 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.86319919 |
176 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.85846482 |
177 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.85712972 |
178 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85699846 |
179 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.84889150 |
180 | SA1_27219007_Chip-Seq_Bcells_Human | 0.84745571 |
181 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82166299 |
182 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.81156611 |
183 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.80570599 |
184 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.80227691 |
185 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.79566123 |
186 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.78337203 |
187 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78103181 |
188 | STAT3_23295773_ChIP-Seq_U87_Human | 0.77280401 |
189 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.76794961 |
190 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.76681052 |
191 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.75723133 |
192 | TBL1_22424771_ChIP-Seq_293T_Human | 0.75633354 |
193 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.75155853 |
194 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.74461919 |
195 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.74356555 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005551_abnormal_eye_electrophysiolog | 9.46597370 |
2 | MP0003011_delayed_dark_adaptation | 9.08477353 |
3 | MP0005253_abnormal_eye_physiology | 6.66574380 |
4 | MP0006072_abnormal_retinal_apoptosis | 6.56208234 |
5 | MP0003724_increased_susceptibility_to | 4.55854452 |
6 | MP0005195_abnormal_posterior_eye | 3.74757505 |
7 | MP0003950_abnormal_plasma_membrane | 3.71071633 |
8 | MP0003303_peritoneal_inflammation | 3.52435515 |
9 | MP0002090_abnormal_vision | 3.37312929 |
10 | MP0003436_decreased_susceptibility_to | 3.25351124 |
11 | MP0005391_vision/eye_phenotype | 3.20725257 |
12 | MP0001324_abnormal_eye_pigmentation | 3.15770050 |
13 | MP0003191_abnormal_cellular_cholesterol | 3.14078114 |
14 | MP0005451_abnormal_body_composition | 2.96146351 |
15 | MP0002638_abnormal_pupillary_reflex | 2.78173646 |
16 | MP0002419_abnormal_innate_immunity | 2.73463522 |
17 | MP0008260_abnormal_autophagy | 2.67406791 |
18 | MP0001835_abnormal_antigen_presentation | 2.66619369 |
19 | MP0001986_abnormal_taste_sensitivity | 2.66169148 |
20 | MP0009785_altered_susceptibility_to | 2.53592754 |
21 | MP0005423_abnormal_somatic_nervous | 2.50081933 |
22 | MP0002229_neurodegeneration | 2.39595520 |
23 | MP0006082_CNS_inflammation | 2.37500646 |
24 | MP0003300_gastrointestinal_ulcer | 2.36477080 |
25 | MP0005025_abnormal_response_to | 2.26658314 |
26 | MP0001984_abnormal_olfaction | 2.09902703 |
27 | MP0005000_abnormal_immune_tolerance | 2.01760165 |
28 | MP0001800_abnormal_humoral_immune | 1.93260085 |
29 | MP0002452_abnormal_antigen_presenting | 1.92772400 |
30 | MP0002148_abnormal_hypersensitivity_rea | 1.90754533 |
31 | MP0002723_abnormal_immune_serum | 1.90326866 |
32 | MP0000685_abnormal_immune_system | 1.88925511 |
33 | MP0001819_abnormal_immune_cell | 1.88134002 |
34 | MP0002420_abnormal_adaptive_immunity | 1.87760888 |
35 | MP0005464_abnormal_platelet_physiology | 1.86082095 |
36 | MP0003828_pulmonary_edema | 1.85590676 |
37 | MP0005387_immune_system_phenotype | 1.81881524 |
38 | MP0001790_abnormal_immune_system | 1.81881524 |
39 | MP0010386_abnormal_urinary_bladder | 1.81303458 |
40 | MP0002752_abnormal_somatic_nervous | 1.78600878 |
41 | MP0002132_abnormal_respiratory_system | 1.75742356 |
42 | MP0001533_abnormal_skeleton_physiology | 1.69364816 |
43 | MP0005671_abnormal_response_to | 1.68227308 |
44 | MP0004947_skin_inflammation | 1.66849815 |
45 | MP0002254_reproductive_system_inflammat | 1.66169937 |
46 | MP0009840_abnormal_foam_cell | 1.62088773 |
47 | MP0006292_abnormal_olfactory_placode | 1.61673658 |
48 | MP0010155_abnormal_intestine_physiology | 1.59049284 |
49 | MP0004782_abnormal_surfactant_physiolog | 1.55470376 |
50 | MP0001845_abnormal_inflammatory_respons | 1.54644321 |
51 | MP0005394_taste/olfaction_phenotype | 1.48117962 |
52 | MP0005499_abnormal_olfactory_system | 1.48117962 |
53 | MP0002405_respiratory_system_inflammati | 1.47941549 |
54 | MP0004019_abnormal_vitamin_homeostasis | 1.44787080 |
55 | MP0000858_altered_metastatic_potential | 1.39555347 |
56 | MP0001764_abnormal_homeostasis | 1.37197154 |
57 | MP0001502_abnormal_circadian_rhythm | 1.35408492 |
58 | MP0000716_abnormal_immune_system | 1.34990309 |
59 | MP0002653_abnormal_ependyma_morphology | 1.33918578 |
60 | MP0002398_abnormal_bone_marrow | 1.33501051 |
61 | MP0008789_abnormal_olfactory_epithelium | 1.33342335 |
62 | MP0004381_abnormal_hair_follicle | 1.31906728 |
63 | MP0000015_abnormal_ear_pigmentation | 1.29923881 |
64 | MP0002396_abnormal_hematopoietic_system | 1.29604875 |
65 | MP0008469_abnormal_protein_level | 1.29026624 |
66 | MP0002998_abnormal_bone_remodeling | 1.26391185 |
67 | MP0009333_abnormal_splenocyte_physiolog | 1.21385433 |
68 | MP0002882_abnormal_neuron_morphology | 1.21323170 |
69 | MP0009278_abnormal_bone_marrow | 1.20974753 |
70 | MP0002332_abnormal_exercise_endurance | 1.19680409 |
71 | MP0003075_altered_response_to | 1.18225205 |
72 | MP0003890_abnormal_embryonic-extraembry | 1.16602750 |
73 | MP0002722_abnormal_immune_system | 1.14568962 |
74 | MP0000689_abnormal_spleen_morphology | 1.13327564 |
75 | MP0002429_abnormal_blood_cell | 1.12118795 |
76 | MP0002877_abnormal_melanocyte_morpholog | 1.08654798 |
77 | MP0003806_abnormal_nucleotide_metabolis | 1.07451507 |
78 | MP0003221_abnormal_cardiomyocyte_apopto | 1.06130392 |
79 | MP0004883_abnormal_blood_vessel | 1.06115814 |
80 | MP0005164_abnormal_response_to | 1.05800319 |
81 | MP0005248_abnormal_Harderian_gland | 1.02972338 |
82 | MP0002166_altered_tumor_susceptibility | 0.99983765 |
83 | MP0004043_abnormal_pH_regulation | 0.98652140 |
84 | MP0005397_hematopoietic_system_phenotyp | 0.98416599 |
85 | MP0001545_abnormal_hematopoietic_system | 0.98416599 |
86 | MP0003763_abnormal_thymus_physiology | 0.97583897 |
87 | MP0004264_abnormal_extraembryonic_tissu | 0.97066019 |
88 | MP0003453_abnormal_keratinocyte_physiol | 0.96450207 |
89 | MP0005197_abnormal_uvea_morphology | 0.95749162 |
90 | MP0004233_abnormal_muscle_weight | 0.95084120 |
91 | MP0001851_eye_inflammation | 0.94756728 |
92 | MP0002127_abnormal_cardiovascular_syste | 0.92548505 |
93 | MP0005075_abnormal_melanosome_morpholog | 0.92513058 |
94 | MP0003566_abnormal_cell_adhesion | 0.91500113 |
95 | MP0003195_calcinosis | 0.89932992 |
96 | MP0003656_abnormal_erythrocyte_physiolo | 0.89644540 |
97 | MP0003448_altered_tumor_morphology | 0.89052812 |
98 | MP0009046_muscle_twitch | 0.88004305 |
99 | MP0002796_impaired_skin_barrier | 0.87632990 |
100 | MP0000490_abnormal_crypts_of | 0.87557846 |
101 | MP0000703_abnormal_thymus_morphology | 0.86395494 |
102 | MP0005166_decreased_susceptibility_to | 0.84815218 |
103 | MP0002139_abnormal_hepatobiliary_system | 0.83462443 |
104 | MP0003690_abnormal_glial_cell | 0.81423000 |
105 | MP0002272_abnormal_nervous_system | 0.79983144 |
106 | MP0005076_abnormal_cell_differentiation | 0.78997058 |
107 | MP0004808_abnormal_hematopoietic_stem | 0.78871761 |
108 | MP0002006_tumorigenesis | 0.77651101 |
109 | MP0001853_heart_inflammation | 0.76336999 |
110 | MP0005319_abnormal_enzyme/_coenzyme | 0.76279674 |
111 | MP0010352_gastrointestinal_tract_polyps | 0.74913922 |
112 | MP0004885_abnormal_endolymph | 0.73945748 |
113 | MP0005408_hypopigmentation | 0.73395766 |
114 | MP0000371_diluted_coat_color | 0.73182423 |
115 | MP0000609_abnormal_liver_physiology | 0.72953991 |
116 | MP0010234_abnormal_vibrissa_follicle | 0.72323914 |
117 | MP0002277_abnormal_respiratory_mucosa | 0.70830754 |
118 | MP0000604_amyloidosis | 0.70143315 |
119 | MP0008004_abnormal_stomach_pH | 0.69089924 |
120 | MP0004510_myositis | 0.67541085 |
121 | MP0003183_abnormal_peptide_metabolism | 0.67061046 |
122 | MP0000569_abnormal_digit_pigmentation | 0.66925719 |
123 | MP0005083_abnormal_biliary_tract | 0.66811386 |
124 | MP0004185_abnormal_adipocyte_glucose | 0.66810893 |
125 | MP0002693_abnormal_pancreas_physiology | 0.66220467 |
126 | MP0000343_altered_response_to | 0.65070471 |
127 | MP0003795_abnormal_bone_structure | 0.63774901 |
128 | MP0005409_darkened_coat_color | 0.63731493 |
129 | MP0005058_abnormal_lysosome_morphology | 0.61866653 |
130 | MP0001346_abnormal_lacrimal_gland | 0.61123232 |
131 | MP0005187_abnormal_penis_morphology | 0.61057496 |
132 | MP0002734_abnormal_mechanical_nocicepti | 0.59443879 |
133 | MP0008058_abnormal_DNA_repair | 0.59075449 |
134 | MP0001486_abnormal_startle_reflex | 0.57989811 |
135 | MP0003634_abnormal_glial_cell | 0.57485731 |
136 | MP0003172_abnormal_lysosome_physiology | 0.56780668 |
137 | MP0001188_hyperpigmentation | 0.56240386 |
138 | MP0005257_abnormal_intraocular_pressure | 0.55519477 |
139 | MP0005310_abnormal_salivary_gland | 0.54305916 |
140 | MP0003879_abnormal_hair_cell | 0.53415799 |
141 | MP0001286_abnormal_eye_development | 0.52460894 |
142 | MP0001293_anophthalmia | 0.49929123 |
143 | MP0004145_abnormal_muscle_electrophysio | 0.49719528 |
144 | MP0002697_abnormal_eye_size | 0.48038423 |
145 | MP0002067_abnormal_sensory_capabilities | 0.46442327 |
146 | MP0008775_abnormal_heart_ventricle | 0.46405854 |
147 | MP0002909_abnormal_adrenal_gland | 0.46328861 |
148 | MP0005595_abnormal_vascular_smooth | 0.46051227 |
149 | MP0002064_seizures | 0.42234463 |
150 | MP0003045_fibrosis | 0.42167892 |
151 | MP0010030_abnormal_orbit_morphology | 0.40928730 |
152 | MP0000631_abnormal_neuroendocrine_gland | 0.39486795 |
153 | MP0004270_analgesia | 0.38737058 |
154 | MP0003941_abnormal_skin_development | 0.38696776 |
155 | MP0004215_abnormal_myocardial_fiber | 0.37315863 |
156 | MP0003635_abnormal_synaptic_transmissio | 0.37081884 |
157 | MP0002138_abnormal_hepatobiliary_system | 0.35325203 |
158 | MP0002184_abnormal_innervation | 0.35260164 |
159 | MP0003880_abnormal_central_pattern | 0.32237831 |
160 | MP0003866_abnormal_defecation | 0.31915404 |
161 | MP0004133_heterotaxia | 0.31120534 |
162 | MP0001963_abnormal_hearing_physiology | 0.30357728 |
163 | MP0000465_gastrointestinal_hemorrhage | 0.28639523 |
164 | MP0005376_homeostasis/metabolism_phenot | 0.28410100 |
165 | MP0003283_abnormal_digestive_organ | 0.27329361 |
166 | MP0008961_abnormal_basal_metabolism | 0.27083958 |
167 | MP0003943_abnormal_hepatobiliary_system | 0.24735472 |
168 | MP0008007_abnormal_cellular_replicative | 0.23819732 |
169 | MP0003111_abnormal_nucleus_morphology | 0.23432635 |
170 | MP0003638_abnormal_response/metabolism_ | 0.22568832 |
171 | MP0002063_abnormal_learning/memory/cond | 0.22540458 |
172 | MP0001501_abnormal_sleep_pattern | 0.22475008 |
173 | MP0000350_abnormal_cell_proliferation | 0.21794190 |
174 | MP0003693_abnormal_embryo_hatching | 0.21545193 |
175 | MP0002572_abnormal_emotion/affect_behav | 0.21328414 |
176 | MP0005670_abnormal_white_adipose | 0.21029500 |
177 | MP0002822_catalepsy | 0.20569168 |
178 | MP0004811_abnormal_neuron_physiology | 0.20345779 |
179 | MP0009764_decreased_sensitivity_to | 0.19705398 |
180 | MP0004858_abnormal_nervous_system | 0.19683922 |
181 | MP0005367_renal/urinary_system_phenotyp | 0.19521912 |
182 | MP0000516_abnormal_urinary_system | 0.19521912 |
183 | MP0000470_abnormal_stomach_morphology | 0.19255947 |
184 | MP0005220_abnormal_exocrine_pancreas | 0.18863754 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Bony spicule pigmentary retinopathy (HP:0007737) | 9.93058859 |
2 | Abnormal rod and cone electroretinograms (HP:0008323) | 9.76857617 |
3 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 9.59534561 |
4 | Pigmentary retinal degeneration (HP:0001146) | 8.29749703 |
5 | Central scotoma (HP:0000603) | 8.10259868 |
6 | Abnormality of macular pigmentation (HP:0008002) | 7.53196342 |
7 | Pendular nystagmus (HP:0012043) | 6.94536017 |
8 | Dyschromatopsia (HP:0007641) | 6.87861367 |
9 | Decreased central vision (HP:0007663) | 6.83214006 |
10 | Chorioretinal atrophy (HP:0000533) | 6.81423796 |
11 | Attenuation of retinal blood vessels (HP:0007843) | 6.75100145 |
12 | Scotoma (HP:0000575) | 6.74917708 |
13 | Eczematoid dermatitis (HP:0000976) | 6.24461815 |
14 | Abolished electroretinogram (ERG) (HP:0000550) | 5.72204246 |
15 | Severe visual impairment (HP:0001141) | 5.60544868 |
16 | Recurrent abscess formation (HP:0002722) | 5.58299661 |
17 | Recurrent bacterial skin infections (HP:0005406) | 5.47935810 |
18 | Photophobia (HP:0000613) | 5.22604905 |
19 | Type II diabetes mellitus (HP:0005978) | 5.17238317 |
20 | Orchitis (HP:0100796) | 5.09803652 |
21 | Increased corneal curvature (HP:0100692) | 5.08177982 |
22 | Keratoconus (HP:0000563) | 5.08177982 |
23 | Myositis (HP:0100614) | 4.94594210 |
24 | Optic neuritis (HP:0100653) | 4.72217583 |
25 | Retrobulbar optic neuritis (HP:0100654) | 4.72217583 |
26 | Macular degeneration (HP:0000608) | 4.61155204 |
27 | Cone-rod dystrophy (HP:0000548) | 4.21455410 |
28 | Choroideremia (HP:0001139) | 4.08774423 |
29 | Posterior subcapsular cataract (HP:0007787) | 4.04639978 |
30 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.03249704 |
31 | Retinitis pigmentosa (HP:0000510) | 3.88218945 |
32 | Constricted visual fields (HP:0001133) | 3.82152824 |
33 | Stomatitis (HP:0010280) | 3.81518563 |
34 | Vitreoretinal degeneration (HP:0000655) | 3.79834700 |
35 | Gastrointestinal infarctions (HP:0005244) | 3.57677512 |
36 | Chronic obstructive pulmonary disease (HP:0006510) | 3.42407119 |
37 | Obstructive lung disease (HP:0006536) | 3.42407119 |
38 | Keratoconjunctivitis sicca (HP:0001097) | 3.41755640 |
39 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.29145510 |
40 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.29145510 |
41 | Abnormality of glycolipid metabolism (HP:0010969) | 3.29145510 |
42 | Recurrent skin infections (HP:0001581) | 3.26865522 |
43 | Recurrent fungal infections (HP:0002841) | 3.24773488 |
44 | Progressive visual loss (HP:0000529) | 3.21000507 |
45 | Mediastinal lymphadenopathy (HP:0100721) | 3.20745785 |
46 | Keratoconjunctivitis (HP:0001096) | 3.12640694 |
47 | Urticaria (HP:0001025) | 3.04075017 |
48 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.00820756 |
49 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.00492753 |
50 | Spontaneous hematomas (HP:0007420) | 2.91609374 |
51 | Gingival bleeding (HP:0000225) | 2.86631231 |
52 | Episodic fever (HP:0001954) | 2.85349439 |
53 | Arterial thrombosis (HP:0004420) | 2.84938770 |
54 | Amyloidosis (HP:0011034) | 2.80457681 |
55 | Anorexia (HP:0002039) | 2.78235785 |
56 | Congenital sensorineural hearing impairment (HP:0008527) | 2.76452370 |
57 | Vacuolated lymphocytes (HP:0001922) | 2.74546254 |
58 | Meningitis (HP:0001287) | 2.70684551 |
59 | Loss of speech (HP:0002371) | 2.69070292 |
60 | Hypochromic microcytic anemia (HP:0004840) | 2.62925233 |
61 | Osteomyelitis (HP:0002754) | 2.60123604 |
62 | Encephalitis (HP:0002383) | 2.58856974 |
63 | Subacute progressive viral hepatitis (HP:0006572) | 2.58184331 |
64 | Vasculitis (HP:0002633) | 2.56582954 |
65 | T lymphocytopenia (HP:0005403) | 2.56446653 |
66 | Hemoptysis (HP:0002105) | 2.54274540 |
67 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.50168279 |
68 | Increased IgE level (HP:0003212) | 2.49935753 |
69 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.48911928 |
70 | Subcapsular cataract (HP:0000523) | 2.47719894 |
71 | Abnormality of T cell number (HP:0011839) | 2.46073868 |
72 | Chest pain (HP:0100749) | 2.44545113 |
73 | Malnutrition (HP:0004395) | 2.43804167 |
74 | Petechiae (HP:0000967) | 2.43503438 |
75 | Prolonged bleeding time (HP:0003010) | 2.37260433 |
76 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.35353805 |
77 | Recurrent cutaneous fungal infections (HP:0011370) | 2.35353805 |
78 | Retinal atrophy (HP:0001105) | 2.34965355 |
79 | Congenital primary aphakia (HP:0007707) | 2.31341475 |
80 | Pulmonary infiltrates (HP:0002113) | 2.30852565 |
81 | Cellulitis (HP:0100658) | 2.29186854 |
82 | Hypochromic anemia (HP:0001931) | 2.27872216 |
83 | Gait imbalance (HP:0002141) | 2.27667210 |
84 | Myocardial infarction (HP:0001658) | 2.27029799 |
85 | Peritonitis (HP:0002586) | 2.27005132 |
86 | Dysostosis multiplex (HP:0000943) | 2.22841145 |
87 | Pulmonary embolism (HP:0002204) | 2.20559925 |
88 | Wide nasal bridge (HP:0000431) | 2.19867552 |
89 | Disinhibition (HP:0000734) | 2.18869537 |
90 | Epistaxis (HP:0000421) | 2.18416529 |
91 | Acne (HP:0001061) | 2.15736920 |
92 | Leukocytosis (HP:0001974) | 2.15669534 |
93 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.14220865 |
94 | Hypoplasia of the fovea (HP:0007750) | 2.14220865 |
95 | Nephrogenic diabetes insipidus (HP:0009806) | 2.12721590 |
96 | Increased CSF protein (HP:0002922) | 2.12028558 |
97 | Increased serum ferritin (HP:0003281) | 2.08272411 |
98 | Cheilitis (HP:0100825) | 2.07593922 |
99 | Pustule (HP:0200039) | 2.06502099 |
100 | Slow saccadic eye movements (HP:0000514) | 2.04984039 |
101 | Progressive neurologic deterioration (HP:0002344) | 2.03048016 |
102 | Abnormality of iron homeostasis (HP:0011031) | 2.03036627 |
103 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.00933953 |
104 | Premature loss of primary teeth (HP:0006323) | 2.00904416 |
105 | Congenital stationary night blindness (HP:0007642) | 17.4124271 |
106 | Septo-optic dysplasia (HP:0100842) | 1.99519539 |
107 | Polycythemia (HP:0001901) | 1.99331548 |
108 | Optic disc pallor (HP:0000543) | 1.99272053 |
109 | Acute hepatic failure (HP:0006554) | 1.96564755 |
110 | Medial flaring of the eyebrow (HP:0010747) | 1.95798819 |
111 | Hepatosplenomegaly (HP:0001433) | 1.95565341 |
112 | Pathologic fracture (HP:0002756) | 1.95502393 |
113 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.95004815 |
114 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.95004815 |
115 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.95004815 |
116 | True hermaphroditism (HP:0010459) | 1.94847703 |
117 | Autoimmune thrombocytopenia (HP:0001973) | 1.92755283 |
118 | Interstitial pulmonary disease (HP:0006530) | 1.91377620 |
119 | Micronodular cirrhosis (HP:0001413) | 1.90028788 |
120 | Gangrene (HP:0100758) | 1.89973185 |
121 | Recurrent viral infections (HP:0004429) | 1.88896050 |
122 | Poor coordination (HP:0002370) | 1.88650021 |
123 | Mucopolysacchariduria (HP:0008155) | 1.87152610 |
124 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.87152610 |
125 | Hematochezia (HP:0002573) | 1.86137583 |
126 | Periodontitis (HP:0000704) | 1.83394411 |
127 | Microcytic anemia (HP:0001935) | 1.82876664 |
128 | Abnormality of the fovea (HP:0000493) | 1.82066719 |
129 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81611702 |
130 | Abnormality of the endocardium (HP:0004306) | 1.81501437 |
131 | Curly hair (HP:0002212) | 1.80195251 |
132 | Abnormality of T cells (HP:0002843) | 1.79270809 |
133 | Keratitis (HP:0000491) | 1.75520053 |
134 | Inflammation of the large intestine (HP:0002037) | 1.75113132 |
135 | Metaphyseal cupping (HP:0003021) | 1.74997024 |
136 | Abnormality of the pleura (HP:0002103) | 1.73711047 |
137 | Skin ulcer (HP:0200042) | 1.70631352 |
138 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.66993267 |
139 | Febrile seizures (HP:0002373) | 1.59815244 |
140 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.55293758 |
141 | Pancreatic fibrosis (HP:0100732) | 1.51057401 |
142 | Optic atrophy (HP:0000648) | 1.50999500 |
143 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.50472372 |
144 | Vaginal atresia (HP:0000148) | 1.50146256 |
145 | Horizontal nystagmus (HP:0000666) | 1.48262909 |
146 | Genital tract atresia (HP:0001827) | 1.43794707 |
147 | Epileptic encephalopathy (HP:0200134) | 1.40453194 |
148 | Albinism (HP:0001022) | 1.36322757 |
149 | Pancreatic cysts (HP:0001737) | 1.34692100 |
150 | Abdominal situs inversus (HP:0003363) | 1.32409872 |
151 | Abnormality of abdominal situs (HP:0011620) | 1.32409872 |
152 | Severe Myopia (HP:0011003) | 1.29860949 |
153 | Increased cerebral lipofuscin (HP:0011813) | 1.27371363 |
154 | Dysdiadochokinesis (HP:0002075) | 1.26040667 |
155 | Astigmatism (HP:0000483) | 1.25313815 |
156 | Progressive cerebellar ataxia (HP:0002073) | 1.24966417 |
157 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.24073175 |
158 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.23373417 |
159 | Cystic liver disease (HP:0006706) | 1.22934081 |
160 | Polar cataract (HP:0010696) | 1.20094452 |
161 | Absence seizures (HP:0002121) | 1.18948187 |
162 | Decreased testicular size (HP:0008734) | 1.15408709 |
163 | Chorioretinal coloboma (HP:0000567) | 1.13935161 |
164 | Cerebellar dysplasia (HP:0007033) | 1.13552134 |
165 | Visual hallucinations (HP:0002367) | 1.06581920 |
166 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.05342340 |
167 | Broad foot (HP:0001769) | 1.04657425 |
168 | Abnormal sex determination (HP:0012244) | 1.01980639 |
169 | Sex reversal (HP:0012245) | 1.01980639 |
170 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.01563691 |
171 | Dialeptic seizures (HP:0011146) | 0.98492744 |
172 | Osteomalacia (HP:0002749) | 0.98099746 |
173 | Specific learning disability (HP:0001328) | 0.93596596 |
174 | Prolonged QT interval (HP:0001657) | 0.92649472 |
175 | Asthma (HP:0002099) | 0.88344385 |
176 | Ependymoma (HP:0002888) | 0.87756724 |
177 | Abnormality of macrophages (HP:0004311) | 0.87386462 |
178 | Truncal ataxia (HP:0002078) | 0.87019797 |
179 | Optic nerve hypoplasia (HP:0000609) | 0.84530324 |
180 | Hyperactive renin-angiotensin system (HP:0000841) | 0.84051931 |
181 | Agnosia (HP:0010524) | 0.81359405 |
182 | Sclerocornea (HP:0000647) | 0.80970072 |
183 | Abnormality of dental color (HP:0011073) | 0.80911800 |
184 | Left ventricular hypertrophy (HP:0001712) | 0.79180281 |
185 | Abnormality of the astrocytes (HP:0100707) | 0.79128605 |
186 | Astrocytoma (HP:0009592) | 0.79128605 |
187 | Cholecystitis (HP:0001082) | 0.78657159 |
188 | Abnormal gallbladder physiology (HP:0012438) | 0.78657159 |
189 | Generalized hypopigmentation (HP:0007513) | 0.77535786 |
190 | Gingivitis (HP:0000230) | 0.77502229 |
191 | Mutism (HP:0002300) | 0.76714329 |
192 | Hypermetropia (HP:0000540) | 0.76077309 |
193 | Hemiparesis (HP:0001269) | 0.76000934 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PBK | 8.57340737 |
2 | GRK1 | 7.20226949 |
3 | NEK1 | 3.36560289 |
4 | IRAK4 | 3.22782681 |
5 | MAP2K3 | 3.10168445 |
6 | CSK | 2.75670528 |
7 | BLK | 2.71150731 |
8 | MST1R | 2.63865344 |
9 | TYK2 | 2.40933224 |
10 | MAP3K3 | 2.35897674 |
11 | EPHB1 | 2.11540089 |
12 | SCYL2 | 2.09455034 |
13 | AKT3 | 2.08392881 |
14 | EPHA2 | 2.08282810 |
15 | ZAP70 | 2.00987353 |
16 | TAOK1 | 1.99195147 |
17 | STK38 | 1.96694081 |
18 | INSRR | 1.93741433 |
19 | MAP4K1 | 1.92601568 |
20 | RPS6KA4 | 1.86278759 |
21 | PINK1 | 1.84033425 |
22 | IRAK2 | 1.82561894 |
23 | FGR | 1.76360662 |
24 | CDK12 | 1.75242782 |
25 | GRK6 | 1.72467966 |
26 | RIPK1 | 1.72098645 |
27 | IRAK3 | 1.69557847 |
28 | FES | 1.66977867 |
29 | STK38L | 1.64149420 |
30 | TAOK3 | 1.60517138 |
31 | NEK2 | 1.60012147 |
32 | JAK3 | 1.55602186 |
33 | PTK6 | 1.49425575 |
34 | CCNB1 | 1.40670196 |
35 | CDK3 | 1.40609792 |
36 | HCK | 1.39241101 |
37 | RPS6KB2 | 1.35856021 |
38 | SIK3 | 1.35711950 |
39 | MAP3K2 | 1.30054683 |
40 | TAOK2 | 1.29320740 |
41 | JAK2 | 1.28043670 |
42 | CAMK1D | 1.27336636 |
43 | TNK2 | 1.23971681 |
44 | STK24 | 1.22952771 |
45 | BMPR2 | 1.18833594 |
46 | MAP3K13 | 1.18736960 |
47 | TTK | 1.16965647 |
48 | TBK1 | 1.16249019 |
49 | BTK | 1.14293001 |
50 | BRD4 | 1.09242516 |
51 | KSR1 | 1.06959374 |
52 | PRKD2 | 1.03583315 |
53 | IKBKE | 1.03369090 |
54 | NME1 | 1.01581849 |
55 | PRPF4B | 0.99509319 |
56 | ACVR1B | 0.99490872 |
57 | LYN | 0.96559685 |
58 | HIPK2 | 0.93791645 |
59 | SGK494 | 0.93384609 |
60 | SGK223 | 0.93384609 |
61 | FGFR4 | 0.93272391 |
62 | STK10 | 0.92590435 |
63 | FGFR3 | 0.92549661 |
64 | MST4 | 0.89358060 |
65 | MAP3K10 | 0.88589671 |
66 | SMG1 | 0.87468622 |
67 | MAP3K12 | 0.86288873 |
68 | ADRBK1 | 0.85880514 |
69 | MAP2K6 | 0.85242671 |
70 | JAK1 | 0.85088959 |
71 | PAK4 | 0.82939650 |
72 | SYK | 0.82491165 |
73 | FER | 0.82445731 |
74 | CAMK2D | 0.82075788 |
75 | LRRK2 | 0.81152942 |
76 | TXK | 0.80703319 |
77 | MARK3 | 0.80298554 |
78 | PRKAA1 | 0.80178617 |
79 | PDPK1 | 0.79741106 |
80 | LCK | 0.78505051 |
81 | TESK2 | 0.78290754 |
82 | MAPK7 | 0.78236471 |
83 | CAMK1G | 0.78008946 |
84 | PRKCZ | 0.77833751 |
85 | MAP3K5 | 0.76697125 |
86 | YES1 | 0.76585027 |
87 | MET | 0.74496092 |
88 | TRIB3 | 0.74196416 |
89 | DYRK3 | 0.73822212 |
90 | ERBB2 | 0.71800770 |
91 | MARK2 | 0.70354407 |
92 | PDK1 | 0.69528854 |
93 | SGK2 | 0.69445974 |
94 | CHEK2 | 0.68869527 |
95 | PRKG2 | 0.67874723 |
96 | RAF1 | 0.67651297 |
97 | DAPK2 | 0.67209721 |
98 | TGFBR2 | 0.65979712 |
99 | ERBB3 | 0.63982394 |
100 | PLK3 | 0.63972274 |
101 | ITK | 0.63627778 |
102 | MAP2K4 | 0.63292641 |
103 | DYRK1A | 0.61575532 |
104 | MAP3K8 | 0.60839394 |
105 | RIPK4 | 0.59401713 |
106 | RET | 0.58784380 |
107 | IRAK1 | 0.57329318 |
108 | TEC | 0.55260216 |
109 | PTK2B | 0.55217633 |
110 | AKT2 | 0.54948130 |
111 | CDK9 | 0.54140416 |
112 | CAMKK1 | 0.53559883 |
113 | CSNK1D | 0.52924240 |
114 | BMX | 0.51607328 |
115 | IKBKB | 0.51276858 |
116 | PNCK | 0.49474471 |
117 | LATS1 | 0.48614057 |
118 | OXSR1 | 0.48400964 |
119 | GRK5 | 0.48207060 |
120 | RPS6KA5 | 0.48006085 |
121 | CLK1 | 0.47995900 |
122 | MATK | 0.47735354 |
123 | ATR | 0.47081567 |
124 | PHKG1 | 0.47041176 |
125 | PHKG2 | 0.47041176 |
126 | CSF1R | 0.47020982 |
127 | CHUK | 0.46554474 |
128 | PRKAA2 | 0.46539530 |
129 | DYRK1B | 0.44912386 |
130 | PLK1 | 0.44208971 |
131 | SGK3 | 0.44011392 |
132 | CAMK1 | 0.43953197 |
133 | TRPM7 | 0.43748122 |
134 | PKN2 | 0.42816135 |
135 | ALK | 0.42330455 |
136 | MAP3K11 | 0.41785520 |
137 | MAPK10 | 0.41409633 |
138 | SIK2 | 0.41109737 |
139 | PIM1 | 0.40303721 |
140 | FRK | 0.40110147 |
141 | PRKCI | 0.39934387 |
142 | PRKCB | 0.39245380 |
143 | STK11 | 0.39138561 |
144 | PIK3CA | 0.38964439 |
145 | FYN | 0.38799593 |
146 | CAMKK2 | 0.38773909 |
147 | NLK | 0.38222182 |
148 | PRKDC | 0.38199522 |
149 | SGK1 | 0.38173958 |
150 | EPHA3 | 0.38124923 |
151 | RPS6KA3 | 0.36746622 |
152 | MAP3K9 | 0.36081809 |
153 | PRKCA | 0.35773910 |
154 | KSR2 | 0.35578857 |
155 | GSK3B | 0.35312826 |
156 | MAPK14 | 0.35055352 |
157 | PAK6 | 0.33941936 |
158 | ICK | 0.33552225 |
159 | ATM | 0.33194613 |
160 | MAP3K6 | 0.32809293 |
161 | PRKACG | 0.32280621 |
162 | MARK1 | 0.31894735 |
163 | CSNK1E | 0.31701252 |
164 | MAP3K1 | 0.30795029 |
165 | MAP3K14 | 0.30688840 |
166 | ERN1 | 0.30498871 |
167 | NTRK3 | 0.29771829 |
168 | DAPK1 | 0.28492930 |
169 | MAP3K4 | 0.27951545 |
170 | MINK1 | 0.27813981 |
171 | WNK1 | 0.26203677 |
172 | CDK7 | 0.25514133 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.82253574 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.69325620 |
3 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.28592902 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.28239302 |
5 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.09185232 |
6 | Phototransduction_Homo sapiens_hsa04744 | 13.9957650 |
7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.93547474 |
8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.90985124 |
9 | GABAergic synapse_Homo sapiens_hsa04727 | 1.83445390 |
10 | Olfactory transduction_Homo sapiens_hsa04740 | 1.72966539 |
11 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.68803213 |
12 | Measles_Homo sapiens_hsa05162 | 1.61765140 |
13 | Malaria_Homo sapiens_hsa05144 | 1.60500171 |
14 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.57334445 |
15 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.55651526 |
16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.52340365 |
17 | Hepatitis C_Homo sapiens_hsa05160 | 1.48048020 |
18 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.43237865 |
19 | Nicotine addiction_Homo sapiens_hsa05033 | 1.38008967 |
20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36190814 |
21 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.35759667 |
22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.35472659 |
23 | Morphine addiction_Homo sapiens_hsa05032 | 1.34540013 |
24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.30498726 |
25 | Circadian rhythm_Homo sapiens_hsa04710 | 1.29281012 |
26 | Shigellosis_Homo sapiens_hsa05131 | 1.27993706 |
27 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.24879719 |
28 | Salmonella infection_Homo sapiens_hsa05132 | 1.24605094 |
29 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.23548785 |
30 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.23194162 |
31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.21174569 |
32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.19723821 |
33 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.17244730 |
34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16761741 |
35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15840805 |
36 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.15134409 |
37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.14747817 |
38 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.14445633 |
39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.14296960 |
40 | Allograft rejection_Homo sapiens_hsa05330 | 1.12506414 |
41 | Hepatitis B_Homo sapiens_hsa05161 | 1.12310149 |
42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.11371027 |
43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.10764694 |
44 | Apoptosis_Homo sapiens_hsa04210 | 1.09284837 |
45 | Insulin secretion_Homo sapiens_hsa04911 | 1.08077842 |
46 | Circadian entrainment_Homo sapiens_hsa04713 | 1.06257487 |
47 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.05905206 |
48 | Mineral absorption_Homo sapiens_hsa04978 | 1.04523618 |
49 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.03431378 |
50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02527193 |
51 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.99877746 |
52 | Endocytosis_Homo sapiens_hsa04144 | 0.99602706 |
53 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.99519528 |
54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.98426422 |
55 | Thyroid cancer_Homo sapiens_hsa05216 | 0.97860364 |
56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.96688566 |
57 | Galactose metabolism_Homo sapiens_hsa00052 | 0.95120017 |
58 | Platelet activation_Homo sapiens_hsa04611 | 0.93973375 |
59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.93503983 |
60 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.91234860 |
61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.89369732 |
62 | Pertussis_Homo sapiens_hsa05133 | 0.89138107 |
63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88765495 |
64 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.87931584 |
65 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.87615841 |
66 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.87191655 |
67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84246169 |
68 | Endometrial cancer_Homo sapiens_hsa05213 | 0.83332393 |
69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82876206 |
70 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.82396968 |
71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.78972984 |
72 | Amoebiasis_Homo sapiens_hsa05146 | 0.76058513 |
73 | Insulin resistance_Homo sapiens_hsa04931 | 0.75706926 |
74 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.75474064 |
75 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73458005 |
76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73045300 |
77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.72404191 |
78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72384651 |
79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71637368 |
80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70166349 |
81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.69483540 |
82 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.68505434 |
83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68374924 |
84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.68132032 |
85 | Bladder cancer_Homo sapiens_hsa05219 | 0.67965166 |
86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67676619 |
87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66574446 |
88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65468570 |
89 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65436067 |
90 | Salivary secretion_Homo sapiens_hsa04970 | 0.64849544 |
91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64478346 |
92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63173147 |
93 | Prostate cancer_Homo sapiens_hsa05215 | 0.62153822 |
94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60486565 |
95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58432071 |
96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55864542 |
97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55839104 |
98 | Purine metabolism_Homo sapiens_hsa00230 | 0.54955635 |
99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54855022 |
100 | Lysosome_Homo sapiens_hsa04142 | 0.54497489 |
101 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.54123597 |
102 | Renin secretion_Homo sapiens_hsa04924 | 0.53947842 |
103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49087699 |
104 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48987212 |
105 | Taste transduction_Homo sapiens_hsa04742 | 0.48631225 |
106 | * SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46811346 |
107 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.46433115 |
108 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45979671 |
109 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45322910 |
110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44907420 |
111 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43970339 |
112 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43337513 |
113 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.43252838 |
114 | Alcoholism_Homo sapiens_hsa05034 | 0.40819036 |
115 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40175070 |
116 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39798759 |
117 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.39382478 |
118 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.39366909 |
119 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37370304 |
120 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.34662522 |
121 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.32769560 |
122 | ABC transporters_Homo sapiens_hsa02010 | 0.32210247 |
123 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30959541 |
124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30798181 |
125 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30783760 |
126 | Cocaine addiction_Homo sapiens_hsa05030 | 0.30193666 |
127 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28417022 |
128 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.27996284 |
129 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.26135534 |
130 | Legionellosis_Homo sapiens_hsa05134 | 0.25993180 |
131 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.25649194 |
132 | Tight junction_Homo sapiens_hsa04530 | 0.25380396 |
133 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.25133103 |
134 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.25032697 |
135 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.25007982 |
136 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.24921851 |
137 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.23048082 |
138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.22942901 |
139 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.21028668 |
140 | Long-term potentiation_Homo sapiens_hsa04720 | 0.20433942 |
141 | Gap junction_Homo sapiens_hsa04540 | 0.20302652 |
142 | Phagosome_Homo sapiens_hsa04145 | 0.20222601 |
143 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.19856228 |
144 | Influenza A_Homo sapiens_hsa05164 | 0.19255810 |
145 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.18997460 |
146 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.17844217 |
147 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.16567497 |
148 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.16534327 |
149 | Base excision repair_Homo sapiens_hsa03410 | 0.16158532 |
150 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.15846186 |
151 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15516812 |
152 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.14991528 |
153 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.14673747 |
154 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.14411967 |
155 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.14070245 |
156 | Other glycan degradation_Homo sapiens_hsa00511 | 0.13967216 |
157 | Tuberculosis_Homo sapiens_hsa05152 | 0.13956914 |
158 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.12998809 |
159 | Adherens junction_Homo sapiens_hsa04520 | 0.12944291 |
160 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.11638683 |
161 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.11514517 |
162 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.11331492 |
163 | Bile secretion_Homo sapiens_hsa04976 | 0.11320886 |
164 | RNA degradation_Homo sapiens_hsa03018 | 0.10915544 |
165 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.10582782 |
166 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.10521658 |
167 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.10505142 |
168 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.10306612 |
169 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.10211207 |